These results were significantly higher than the specificity and sensitivity values of AFP (67.69 and 96.15%) correspondingly in HCC patients that means glypican-3 is an essential diagnostic marker of HCC at the initial stage. The gene discussed is GPC3; the disease is hepatocellular carcinoma.